Roberts Andrea L, Townsend Mary K, Chibnik Lori B, Kubzansky Laura D, Tworoger Shelley S
Department of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA, United States.
Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, United States.
J Natl Cancer Inst. 2025 May 1;117(5):989-996. doi: 10.1093/jnci/djae348.
Several studies have suggested that depression may be associated with increased risk of ovarian cancer. Less is known about whether timing matters regarding when depression occurs. To provide evidence for an etiologically relevant exposure period, we examined depression occurring during the time in which precursor lesions develop and progress to invasive carcinoma with the risk of developing ovarian cancer.
Using data from 2 prospective cohorts (1992-2015), we divided follow-up into consecutive 2-year periods for analytic purposes, referred to as "cancer ascertainment periods." We estimated associations of depression in the 10 years before each cancer ascertainment period with incident cancer, using Cox proportional hazards models. Next, we estimated associations of depression occurring up to 18 years before each ascertainment period, in 2-year increments, with incident cancer. We adjusted for demographic, health, and behavioral factors. All tests of statistical significance were two-sided, with a P-value threshold of less than .05.
Depression occurring in the 10 prior years was associated with 30% greater risk of cancer (hazard ratio [HR] = 1.30, 95% confidence interval = 1.15 to 1.46). Associations were similar in fully adjusted models (HR = 1.27). Depression occurring in the 14 years before ascertainment was associated with elevated risk, although only estimates for depression 0-2, 6-8, and 8-10 years before ascertainment reached statistical significance (HR range = 1.20-1.36).
Depression occurring up to 14 years before cancer ascertainment was associated with greater cancer risk. This is the time of precursor progression to invasive ovarian carcinoma, suggesting depression may be an ovarian cancer-promoting agent.
多项研究表明,抑郁症可能与卵巢癌风险增加有关。抑郁症发生的时间是否重要,目前所知较少。为了提供病因学相关暴露期的证据,我们研究了在前体病变发展并进展为浸润性癌且有患卵巢癌风险的时间段内发生的抑郁症。
利用两个前瞻性队列(1992 - 2015年)的数据,为分析目的将随访分为连续的2年时间段,称为“癌症确诊期”。我们使用Cox比例风险模型估计每个癌症确诊期前10年内抑郁症与新发癌症的关联。接下来,我们以2年为增量估计每个确诊期前长达18年发生的抑郁症与新发癌症的关联。我们对人口统计学、健康和行为因素进行了调整。所有统计学显著性检验均为双侧检验,P值阈值小于0.05。
前10年发生的抑郁症与癌症风险增加30%相关(风险比[HR]=1.30,95%置信区间=1.15至1.46)。在完全调整模型中关联相似(HR = 1.27)。确诊前第14年发生的抑郁症与风险升高相关,尽管只有确诊前0 - 2年、6 - 8年和8 - 10年的抑郁症估计值达到统计学显著性(HR范围 = 1.20 - 1.36)。
癌症确诊前长达14年发生的抑郁症与更高的癌症风险相关。这是前体进展为浸润性卵巢癌的时期,提示抑郁症可能是一种促进卵巢癌的因素。